John Wolobin
Analyst
Citizens JMP
Equibles does not estimate personal net worth.
About John Wolobin
John Wolobin is recorded as Analyst at Citizens JMP. John Wolobin has spoken on 9 investor events across 2 companies, most recently for DBV Technologies S.A. on September 9, 2026. Those appearances were for DBV Technologies S.A. (DBVT) and DBV TECHNOLOGIES. The companies whose calls John Wolobin spoke on are classified in the Healthcare sector.
John Wolobin on recent calls
“Just wondering, without knowing the true context or size of these changes, any chance that this could get pushed to 4Q, or is this going to be relatively easy to maneuver through?”
“Just wondering, without knowing the true context or size of these changes, any chance that this could get pushed to 4Q, or is this going to be relatively easy to maneuver through?”
“Just wondering, without knowing the true context or size of these changes, any chance that this could get pushed to 4Q, or is this going to be relatively easy to maneuver through?”
“Just wondering, without knowing the true context or size of these changes, any chance that this could get pushed to 4Q, or is this going to be relatively easy to maneuver through?”
“Just wondering, without knowing the true context or size of these changes, any chance that this could get pushed to 4Q, or is this going to be relatively easy to maneuver through?”
Affiliation history
-
Citizens JMP
Analyst
Transcript header (unverified)
Current
Company network
DBV TECHNOLOGIES
Biotechnology · Healthcare
3 appearances
Latest appearance 2026-07-23
Recent activity
-
-
Conference
APA-AAI Conference 2026
DBV TECHNOLOGIES
-
-
Conference
DBV Update Conference Call
DBV TECHNOLOGIES
-
-
-
Conference
H.C. Wainwright BioConnect Conference
DBV TECHNOLOGIES
-
Annual General Meeting American Academy of Allergy, Asthma & Immunology Annual Meeting 2026 DBV Technologies S.A. (DBVT)
-